121 related articles for article (PubMed ID: 17564577)
1. [Prevalence of hepatitis B virus markers and risk factors associated in haemodialysis patients from Havana City; 2002-2003].
Montalvo MC; Delgado G; Díaz M; de los Angeles Rodríguez Lay L
Nefrologia; 2007; 27(2):234-5. PubMed ID: 17564577
[No Abstract] [Full Text] [Related]
2. Hepatitis B prevalence among workers in Turkey at low risk for hepatitis B exposure.
Güven R; Ozcebe H; Cakir B
East Mediterr Health J; 2006 Nov; 12(6):749-57. PubMed ID: 17333819
[No Abstract] [Full Text] [Related]
3. HBsAg and aflatoxins in sera of rural (Igbo-Ora) and urban (Ibadan) populations in Nigeria.
Olubuyide IO; Maxwell SM; Akinyinka OO; Hart CA; Neal GE; Hendrickse RG
Afr J Med Med Sci; 1993 Dec; 22(4):77-80. PubMed ID: 7839935
[TBL] [Abstract][Full Text] [Related]
4. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B in refugees, guessing the prevalence.
Debes JD
Hepatology; 2010 Aug; 52(2):802-3. PubMed ID: 20683977
[No Abstract] [Full Text] [Related]
6. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico].
Valerio-Ureña J; Vásquez-Fernández F; Pérez-Sosa JA; Cortazar-Benitez LF; Chávez-Tapia NC; Ruvalcaba-Rojas OA; Torres-Medina V; Ocejo-Rodríguez A
Gac Med Mex; 2009; 145(3):183-7. PubMed ID: 19685823
[TBL] [Abstract][Full Text] [Related]
7. [Seroreactivity to hepatitis B virus surface antigen among different population groups in the City of Durango, Mexico].
Alvarado-Esquivel C; Sifuentes-Alvarez A; Pérez-Ochoa JF; García-Corral N; Rodríguez-Briones A; González-Castañeda JL; Alonso-Muñoz CM; Bracho-Huemoeller A
Gac Med Mex; 2008; 144(6):481-4. PubMed ID: 19112719
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis B surface antigen (HBsAg) among apparently healthy human adults seen at the Central Public Health Laboratory, Yaba, Lagos.
Obi CL; Esumeh FI; Igumbor EO; Oyewole F; Olubunmi FA
Cent Afr J Med; 1993 Apr; 39(4):81-3. PubMed ID: 8306391
[No Abstract] [Full Text] [Related]
9. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
[TBL] [Abstract][Full Text] [Related]
10. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination.
Salleras L; Domínguez A; Bruguera M; Plans P; Costa J; Cardeñosa N; Batalla J; Plasència A
Vaccine; 2007 Dec; 25(52):8726-31. PubMed ID: 18045753
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous hepatitis B surface antigen clearance in patients on chronic dialysis.
Piazza V; Efficace E; Montagna G; Segagni S; Ungaretti M; Boselli E; Salvadeo A
Nephrol Dial Transplant; 1996 Jul; 11(7):1489-90. PubMed ID: 8815428
[No Abstract] [Full Text] [Related]
12. Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy).
Majori S; Baldo V; Tommasi I; Malizia M; Floreani A; Monteiro G; Ferrari A; Accordini A; Guzzo P; Baldovin T
J Travel Med; 2008; 15(5):323-7. PubMed ID: 19006505
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of hepatitis B in Canadian blood donors.
O'Brien SF; Xi G; Fan W; Yi QL; Fearon MA; Scalia V; Goldman M
Transfusion; 2008 Nov; 48(11):2323-30. PubMed ID: 18647366
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
15. [Hepatitis B virus circulation in patients studied at the University Hospital of Bucharest].
Debeleac L; Popa MI; Bălaş A; Iancu A; Popa L; Iancu G
Bacteriol Virusol Parazitol Epidemiol; 1995; 40(1):37-40. PubMed ID: 7579947
[No Abstract] [Full Text] [Related]
16. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey.
Akcam FZ; Uskun E; Avsar K; Songur Y
Int J Infect Dis; 2009 Mar; 13(2):274-84. PubMed ID: 18945630
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
Challine D; Chevaliez S; Pawlotsky JM
Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
[TBL] [Abstract][Full Text] [Related]
18. Anti-HBs prevalence in hemodialysed patients with acute renal failure.
Babes VT; Tatu A; Filipescu Z
Virologie; 1979; 30(3):229-30. PubMed ID: 538883
[No Abstract] [Full Text] [Related]
19. [Seroprevalence of hepatitis B in blood donors in Guinea].
Loua A; Diallo MB; Magassouba FB; Camara M; Bah MA; Cisse A
Med Trop (Mars); 2005 Sep; 65(4):396-7. PubMed ID: 16548500
[No Abstract] [Full Text] [Related]
20. Prevalence and trends of markers of hepatitis C virus, hepatitis B virus and human immunodeficiency virus in Delhi blood donors: a hospital based study.
Pahuja S; Sharma M; Baitha B; Jain M
Jpn J Infect Dis; 2007 Nov; 60(6):389-91. PubMed ID: 18032841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
